We are live on ! Find out more
CORV

Correvio Pharma Corp. Ordinary Shares (Canada)
CORV

Delisted

CORV was delisted on the 26th of May, 2020.

30 hedge funds and large institutions have $105M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

22% more capital invested

Capital invested by funds: $85.5M → $105M (+$19.1M)

9% less funds holding

Funds holding: 3330 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

81% less call options, than puts

Call options by funds: $328K | Put options by funds: $1.73M

Holders
30
Holders Change
-3
Holders Change %
-9.09%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
12
Reduced
9
Closed
7
Calls
$328K
Puts
$1.73M
Net Calls
-$1.4M
Net Calls Change
-$199K
Name Holding Trade Value Shares
Change
Change in
Stake
CLOS
26
Compagnie Lombard Odier SCmA
Switzerland
$1K
KF
27
Krilogy Financial
Missouri
$1K +$553 +60 New
Creative Planning
28
Creative Planning
Kansas
$1K +$1.1K +120 New
Deutsche Bank
29
Deutsche Bank
Germany
-$137K -14,599 Closed
KPF
30
K2 Principal Fund
Ontario, Canada
-$128K -13,579 Closed
Northern Trust
31
Northern Trust
Illinois
-$114K -12,107 Closed
PCM
32
Prelude Capital Management
New York
-$28K -3,000 Closed
Simplex Trading
33
Simplex Trading
Illinois
-$20.9K -2,268 -97%
Walleye Trading
34
Walleye Trading
New York
-$7K -700 Closed
Citigroup
35
Citigroup
New York
+$184 +20 New

CORV Hedge Fund Activity: Q3 2015 in Review

30 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q3 2015, worth a combined $105M — up 22% from $85.5M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CORV and 4 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 12 added.

The largest buyer was Putnam Investments, adding an estimated $8.89M. The largest seller was Group One Trading, cutting an estimated $579K.

  • 30 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q3 2015, down from 33 in Q2 2015.
  • Funds reported $105M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q3 2015, up 22% quarter-over-quarter.
  • 4 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q3 2015 and 7 closed out, a net change of -3 holders.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q3 2015 was Putnam Investments, an estimated $8.89M added.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q3 2015 was Group One Trading, an estimated $579K sold.

Based on aggregated 13F filings for Q3 2015.